Full Year 2023 Poxel SA Earnings Call TranscriptOct 03, 2024€0.353 (-1.60%)Earnings- Half Year 2023 Poxel SA Earnings Call TranscriptSep 26, 2023€0.50325Earnings
- Q4 2022 Poxel SA Earnings Call TranscriptMar 23, 2023€0.76Earnings
- Half Year 2022 Poxel SA Earnings Call TranscriptSep 21, 2022€2.05 (-1.56%)Earnings
- Full Year 2021 Poxel SA Earnings Call TranscriptMar 22, 2022€2.72 (+0.63%)Earnings
- Half Year 2021 Poxel SA Earnings Call(English) TranscriptSep 23, 2021€6.29 (-4.66%)Earnings
- Poxel SA New Strategic Direction with Increasing Focus on Rare Metabolic Diseases Corporate Call TranscriptJul 12, 2021
- Full Year 2020 Poxel SA Earnings Call TranscriptMar 25, 2021€6.73Earnings
- Poxel S.A. - Special Call TranscriptDec 14, 2020
- Poxel S.A. - Special Call TranscriptOct 01, 2020
- Half Year 2020 Poxel SA Earnings Call TranscriptSep 15, 2020€6.59 (+6.38%)Earnings
- Full Year 2019 Poxel SA Earnings Call TranscriptMar 26, 2020€6.17 (+5.16%)Earnings
- Poxel SA - Special Call TranscriptDec 20, 2019
- Poxel SA - Special Call TranscriptNov 26, 2019
- Half Year 2019 Poxel SA Earnings Call TranscriptAug 26, 2019€6.38Earnings
- Poxel SA - Special Call TranscriptJun 25, 2019
- Poxel SA - Special Call TranscriptApr 09, 2019
- Full Year 2018 Poxel SA Earnings Call TranscriptMar 21, 2019€7.89 (-2.29%)Earnings
Half Year 2023 Poxel SA Earnings Call Transcript
© -
Hello, everyone, and welcome to this live webcast on the occasion of the release of the half year financial results of the company, Poxel. So today, we are pleased to welcome Thomas Kuhn, Chief Executive Officer; Pascale Fouqueray, Vice President, Clinical Development, Regulatory Affairs and Fanny Bosa, Vice President, Finance, who will give you an insight on the financial results over the course of the first half of 2023 of the company.
During the presentation, you can ask questions and the questions are below your screen on the right. The management will address them at the end of the presentation. Thank you, everyone. I'm now giving you the floor to you, Mr. Kuhn.
Thank you very much. Good morning, good afternoon, everyone. Thank you for joining us today. I'm Thomas Kuhn, the CEO of Poxel. And I'm today with Pascale Fouqueray in charge of Clinical Development and Regulatory Affairs at Poxel and with Fanny Bose in charge of finances at Poxel.
After my
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
